Lymph nodes

Differential Diagnosis in Surgical Pathology

Volumn , Issue , 2010, Pages 745-789

  Loew, Jerome M ^a   Macon, William R ^b,c  

^a RUSH MEDICAL COLLEGE   (United States)

^b Mayo Clinic   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882927987     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4580-9.00014-9     Document Type: Chapter

References (93)

1. Bryant RJ, Banks PM, O'Malley DP Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders. Histopathology 2006, 48:505-515.
2. Hartsock RJ Reactive lesions in lymph nodes. The Reticuloendothelial System. International Academy of Pathology Monograph #16 1975, 153-183. Williams & Wilkins, Baltimore. J.W. Rebuck, C.W. Berard (Eds.).
3. Quijano G, Siminovich M, Drut R Histopathologic findings in the lymphoid and reticuloendothelial system in pediatric HIV infection: A postmortem study. Pediatr Pathol Lab Med 1997, 17:845-856.
4. Baroni CD, Uccini S The lymphadenopathy of HIV infection. Am J Clin Pathol 1993, 99:397-401.
5. Wood GS The immunohistology of lymph nodes in HIV infection: A review. Prog AIDS Pathol 1990, 2:25-32.
6. Kojima M, Sugiura I, Itoh H, et al. Histological varieties of Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in middle-aged and elderly patients: A study of six cases. Pathol Res Pract 2006, 202:609-615.
7. Kojima M, Nakamura S, Shimizu K, et al. Reactive lymphoid hyperplasia of the lymph nodes with giant follicles: A clinicopathologic study of 14 Japanese cases, with special reference to Epstein-Barr virus infection. Int J Surg Pathol 2005, 13:267-272.
8. Reynolds DJ, Banks PM, Gulley ML New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease. Am J Pathol 1995, 146:379-388.
9. Farhi DC, Wells SJ, Siegel RJ Syphilitic lymphadenopathy: Histology and human immunodeficiency virus status. Am J Clin Pathol 1999, 112:330-334.
10. Singh AE, Romanowski B Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999, 12:187-209.
11. Lin MH, Kuo TT Specificity of the histopathological triad for the diagnosis of toxoplasmic lymphadenitis: Polymerase chain reaction study. Pathol Int 2001, 51:619-623.
12. Rose I Morphology and diagnostics of human toxoplasmosis. Gen Diagn Pathol 1997, 142:257-270.
13. Dorfman RF, Remington JS Value of lymph node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med 1973, 298:878-881.
14. Winter LK, Spiegel JH, King T Dermatopathic lymphadenitis of the head and neck. J Cutan Pathol 2007, 34:195-197.
15. Chang CC, Osipov V, Wheaton S, et al. Follicular hyperplasia, follicular lysis, and progressive transformation of germinal centers: A sequential spectrum of morphologic evolution in lymphoid hyperplasia. Am J Clin Pathol 2003, 120:322-326.
16. Nguyen PL, Ferry JA, Harris NL Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: A comparative immunohistochemical study. Am J Surg Pathol 1999, 23:27-33.
17. Worth A, Thrasher AJ, Gaspar HB Autoimmune lymphoproliferative syndrome: Molecular basis of disease and clinical phenotype. Br J Haematol 2006, 133:124-140.
18. Poppema S Autoimmune lymphoproliferative syndrome USCAP, 2004. Available at. http://www.uscap.org/site~/93rd/companion21h6.htm.
19. Qian X, Jin L, Hayden RT, et al. Diagnosis of cat scratch disease with Bartonella henselae infection in formalin-fixed paraffin-embedded tissues by two different PCR assays. Diagn Mol Pathol 2005, 14:146-151.
20. Lamps LW, Scott MA Cat-scratch disease: Historic, clinical, and pathologic perspectives. Am J Clin Pathol 2004, 121(Suppl):S71-S80.
21. Miller-Catchpole R, Variakojis D, Vardiman JW, et al. Cat scratch disease: Identification of bacteria in seven cases of lymphadenitis. Am J Surg Pathol 1986, 10:276-281.
22. Joseph L, Scott MA, Schichman SA, Zent CS Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 2001, 68:287-291.
23. Gaffey MJ, Ben-Ezra JM, Weiss LM Herpes simplex lymphadenitis. Am J Clin Pathol 1991, 95:709-714.
24. Bosch X, Guilabert A, Miquel R, Campo E Enigmatic Kikuchi-Fujimoto disease: A comprehensive review. Am J Clin Pathol 2004, 122:141-152.
25. Onciu M, Medeiros LJ Kikuchi-Fujimoto lymphadenitis. Adv Anat Pathol 2003, 10:204-211.
26. Willard-Mack CL Normal structure, function, and histology of lymph nodes. Toxicol Pathol 2006, 34:409-424.
27. Ghirardelli ML, Jemos V, Gobbi PG Diagnostic approach to lymph node enlargement. Haematologica 1999, 84:242-247.
28. McClain KL, Natkunam Y, Swerdlow SH Atypical cellular disorders. Hematol Am Soc Hematol Educ Prog 2004, 1:283-296.
29. Frizzera G Castleman's disease and related disorders. Semin Diagn Pathol 1988, 5:346-364.
30. Keller AR, Hochholzer L, Castleman B Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of mediastinum and other locations. Cancer 1972, 29:670-683.
31. Gupta R, Bain BJ, Knight CL Cytogenetic and molecular genetic abnormalities in systemic mastocytosis. Acta Haematol 2002, 107:123-128.
32. Horny H-P, Akin C, Metcalfe DD, et al. Mastocytosis. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 54-63. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
33. Bain BJ Systemic mastocytosis and other mast cell neoplasms. Br J Haematol 1999, 106:9-17.
34. Cohen AD, Zhou P, Xiao Q, et al. Systemic AL amyloidosis due to non-Hodgkin's lymphoma: An unusual clinicopathologic association. Br J Haematol 2004, 124:309-314.
35. Kutlay S, Hasan T, Keven K, et al. Primary amyloidosis presenting with massive generalized lymphadenopathy. Leuk Lymph 2002, 43:1501-1503.
36. McClain KL, Natkunam Y, Swerdlow SH Atypical cellular disorders. Hematol Am Soc Hematol Educ Prog 2004, 1:283-296.
37. Slone SP, Fleming DR, Buchino JJ Sinus histiocytosis with massive lymphadenopathy and Langerhans cell histiocytosis express the cellular adhesion molecule CD31. Arch Pathol Lab Med 2003, 127:341-344.
38. Foucar E, Rosai J, Dorfman R Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Review of the entity. Semin Diagn Pathol 1990, 7:19-73.
39. Avram MM, Gobel V, Sepehr A Case records of the Massachusetts General Hospital. Case 30-2007. A newborn girl with skin lesions. N Engl J Med 2007, 357:1327-1335.
40. McClain KL, Natkunam Y, Swerdlow SH Atypical cellular disorders. Hematol Am Soc Hematol Educ Prog 2004, 1:283-296.
41. Herzog KM, Tubbs RR Langerhans cell histiocytosis. Adv Anat Pathol 1998, 5:347-358.
42. Lazarus AA, Thilagar B Tuberculous lymphadenitis. Dis Mon 2007, 53:10-15.
43. Polesky A, Grove W, Bhatia G Peripheral tuberculous lymphadenitis: Epidemiology, diagnosis, treatment, and outcome. Medicine (Baltimore) 2005, 84:350-362.
44. Brugge WR, Mueller PR, Misdraji J Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-2004. A 28-year-old man with abdominal pain, fever, and a mass in the region of the pancreas. N Engl J Med 2004, 350:1131-1138.
45. Woods GL Molecular methods in the detection and identification of mycobacterial infections. Arch Pathol Lab Med 1999, 123:1002-1006.
46. Yan JJ, Chen FF, Jin YT, et al. Differentiation of BCG-induced lymphadenitis from tuberculosis in lymph node biopsy specimens by molecular analyses of pncA and oxyR. J Pathol 1998, 184:96-102.
47. Rosen Y Pathology of sarcoidosis. Semin Respir Crit Care Med 2007, 28:36-52.
48. Zissel G, Prasse A, Muller-Quernheim J Sarcoidosis: Immunopathogenetic concepts. Semin Respir Crit Care Med 2007, 28:3-14.
49. Isaacson PG Hematopathology practice: The commonest problems encountered in a consultation practice. Histopathology 2007, 50:821-834.
50. Cerhan JR, Wang S, Maurer MJ, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007, 109:5439-5446.
51. de Jong D Molecular pathogenesis of follicular lymphoma: A cross talk of genetic and immunologic factors. J Clin Oncol 2005, 23:6358-6363.
52. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004, 351:2159-2169.
53. Harris NL, Nathwani BN, Swerdlow SH, et al. Follicular lymphoma. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 220-226. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
54. Bakshi NA, Finn WG, Schnitzer B, et al. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma. Arch Pathol Lab Med 2007, 131:742-747.
55. Brauninger A, Schmitz R, Bechtel D, et al. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer 2006, 118:1853-1861.
56. Stein H, von Wasielewski R, Poppema S, et al. Nodular sclerosis classical Hodgkin lymphoma. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 330. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
57. Nogova L, Rudiger T, Engert A Biology, clinical course and management of nodular lymphocyte-predominant Hodgkin lymphoma. Hematol Am Soc Hematol Educ Prog 2006, 1:266-272.
58. Poppema S, Swerdlow SH, Delsol G, et al. Nodular lymphocyte predominant Hodgkin lymphoma. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 323-325. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
59. Thieblemont C, Nasser V, Felman P, et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 2004, 103:2727-2737.
60. Müller-Hermelink HK, Montserrat E, Catovsky D, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 180-182. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
61. Chen CC, Raikow RB, Sonmez-Alpan E, Swerdlow SH Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Mol Morphol 2000, 8:1-11.
62. Leoncini L, Delsol G, Gascoyne RD, et al. Aggressive B-cell lymphomas: A review based on the workshop of the XI Meeting of the European Association for Haematopathology. Histopathology 2005, 46:241-255.
63. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003, 3:185-197.
64. Swerdlow SH, Campo E, Seto M, et al. Mantle cell lymphoma. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 229-232. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
65. Traverse-Glehen A, Felman P, Callet-Bauchu E, et al. A clinicopathological study of nodal marginal zone B-cell lymphoma: A report on 21 cases. Histopathology 2006, 48:162-173.
66. Campo E, Pileri SA, Jaffe ES, et al. Nodal marginal zone lymphoma. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 218-219. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
67. Remstein ED, James CD, Kurtin PJ Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000, 156:1183-1188.
68. Shivakumar L, Armitage JO Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma. Clin Lymphoma Myeloma 2006, 6:455-457.
69. Winter JN, Weller EA, Horning SJ, et al. Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: A prospective correlative study. Blood 2006, 107:4207-4213.
70. Stein H, Warnke RA, Chan WC, et al. Diffuse large B-cell lymphoma, not otherwise specified. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 233-237. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
71. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
72. Borowitz M, Chan JKC B lymphoblastic leukaemia/lymphoma, not otherwise specified. World Health Classification: Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, 168-170. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
73. Soslow RA, Baergen RN, Warnke RA B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer 1999, 85:2648-2654.
74. Yeh KH, Cheng AL, Su IJ, et al. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. Anticancer Res 1997, 17:2269-2272.
75. Amin HM, Lai R Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood 2007, 110:2259-2267.
76. Kinney MC, Kadin ME The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol 1999, 111:S56-S67.
77. Benharroch D, Meguerian-Bodoyan Z, Lamant L, et al. ALK-positive lymphoma: A single disease with a broad spectrum of morphology. Blood 1998, 91:2076-2084.
78. Harris NL, Horning SJ Burkitt's lymphoma: The message from microarrays. N Engl J Med 2006, 354:2495-2498.
79. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006, 354:2419-2430.
80. McClure RF, Remstein ED, Macon WR, et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behaviour. Am J Surg Pathol 2005, 29:1652-1660.
81. Attygalle AD, Chuang S-S, Diss TC, et al. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics. Histopathology 2007, 50:498-508.
82. Streubel B, Vinatzer U, Willheim M, et al. Novel t(5;9) (q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006, 20:313-318.
83. ten Berge RL, de Bruin PC, Oudejans JJ, et al. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology 2003, 43:462-469.
84. Chan JK Peripheral T-cell and NK-cell neoplasms: an integrated approach to diagnosis. Mod Pathol 1999, 12:177-199.
85. Willenbrock K, Bräuninger A, Hansmann M-L Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 2007, 138:733-739.
86. Grogg KL, Attygalle AD, Macon WR, et al. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006, 19:1101-1107.
87. Dogan A, Attygalle AD, Kyriakou C Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003, 121:681-691.
88. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T-cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002, 99:627-633.
89. Brauninger A, Schmitz R, Bechtel D, et al. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer 2006, 118:1853-1861.
90. Tzankov A, Dirnhofer S Pathobiology of classical Hodgkin lymphoma. Pathobiology 2006, 73:107-125.
91. Weiss LM, von Wasielewski R, Delsol G, et al. Mixed cellularity classical Hodgkin lymphoma. World Health Organization: Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008, 331. IARC, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
92. Paydas S, Zorludemir S, Ergin M Granulocytic sarcoma: 32 Cases and review of the literature. Leuk Lymphoma 2006, 47:2527-2541.
93. Kojima M, Nakamura S, Shimizu K, et al. Granulocytic sarcoma presenting with lymph node infarction at disease onset. APMIS 2003, 111:1133-1136.